LabTurbo Biotech Profit Margin

LabTurbo Biotech (7725.TWO) currently reports a profit margin of -121.1% as of June 2026. That is below the Healthcare sector average of 10.58%. Use the charts on this page to explore LabTurbo Biotech's profit margin history and peer comparisons.

LabTurbo Biotech's profit margin of -121.1% is lower than the Healthcare sector average of 10.58%. That is roughly 1244.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but LabTurbo Biotech's current -121.1% should be judged against Healthcare norms (sector average: 10.58%) and against 7725.TWO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -121.1%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 10.58%. From there, open related valuation or income-statement pages for LabTurbo Biotech, and consider following 7725.TWO for alerts when major investors trade the stock.

LabTurbo Biotech is classified in the Healthcare sector. On profit margin, it currently shows -121.1% versus a sector average near 10.58%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 7725.TWO with unrelated industries.